文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌消化内镜

退伍军人人群中巴雷特食管诊断内镜漏诊异型增生的患病率与预测因素

Prevalence and Predictors of Missed Dysplasia on Index Barrett's Esophagus Diagnosing Endoscopy in a Veteran Population.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-04-08

该回顾性队列研究分析了1990-2019年休斯顿VA医疗中心614例巴雷特食管(BE)患者,其中271例非异型增生BE(NDBE)患者在3-18个月内复查内镜,4.1%发现明确异型增生,另14.0%为不确定异型增生。长段BE(≥3 cm)是漏诊异型增生的独立预测因素(OR 3.39,95%CI 1.63-7.08)。

要点

  • NDBE患者3-18个月内复查内镜,4.1%发现明确异型增生,14.0%为不确定异型增生。
  • 长段BE(≥3 cm)患者漏诊异型增生风险增加3倍以上(OR 3.39,95%CI 1.63-7.08)。

核心结论

  • 索引内镜漏诊异型增生的发生率随时间下降,但长段BE患者漏诊风险仍显著增高,可能受益于BE诊断后18个月内的异型增生监测。

研究设计与样本

  • 回顾性队列分析,纳入1990-2019年休斯顿VA医疗中心索引内镜诊断为BE的患者614例,其中NDBE且3-18个月内复查内镜者271例。

主要发现

  • 271例NDBE复查患者中,4.1%发现明确异型增生,另14.0%为不确定异型增生。
  • 复查发现异型增生(n=49)的患者索引内镜时BE长度≥3 cm的比例更高(OR 3.39,95%CI 1.63-7.08)。

关键数值与推荐

  • BE长度≥3 cm的NDBE患者漏诊异型增生风险显著增加(OR 3.39,95%CI 1.63-7.08)。
  • NDBE患者3-18个月内复查内镜,明确异型增生检出率为4.1%,不确定异型增生为14.0%。

临床怎么用

  • 对长段BE(≥3 cm)的非异型增生BE患者,可考虑在诊断后18个月内进行异型增生监测内镜。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Limitations of endoscopic sampling may result in missed dysplasia at the diagnosis of Barrett's esophagus (BE). However, the role of close follow-up endoscopy is unclear. The aim was to evaluate the proportion of patients diagnosed with "missed" dysplasia within 18 months of their index nondysplastic BE (NDBE) diagnosis. METHODS: This was a retrospective analysis of a cohort of BE patients diagnosed during 1990-2019 at the Houston VA. Patients with BE on index esophagogastroduodenoscopy (EGD) were classified as NDBE, indefinite dysplasia, or dysplastic (low- or high-grade dysplasia) based on initial biopsies. We identified NDBE patients who had follow-up EGD within 3-18 months after index EGD. We used logistic regression models to estimate odds ratios and 95% confidence intervals for risk factors of dysplasia on follow-up EGD. RESULTS: We identified 614 patients who had BE on index EGD. Among those with NDBE and follow-up EGD within 3-18 months (n = 271), 4.1% had definite dysplasia on follow-up, and an additional 14.0% had indefinite dysplasia. Proportions of definite or indefinite dysplasia at follow-up within 3-18 months significantly decreased from 32.6% among patients with index EGD before 2009 to 11.7% among patients with index EGD after 2013 (P for trend = .068). Those with any indefinite or definite dysplastic BE at follow-up within 3-18 months after index EGD (n = 49) were more likely to have BE length ≥3 cm on index EGD (odds ratio, 3.39; 95% confidence interval, 1.63-7.08) than those with persistent NDBE or no BE on follow-up. CONCLUSIONS: The occurrence of missed dysplasia on an index EGD has decreased over time. However, those with long segment BE were more than 3 times as likely to have missed dysplasia, and this group could benefit from dysplasia surveillance within 18 months of BE diagnosis.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Nguyen TH, Thrift AP, George R, et al. Prevalence and Predictors of Missed Dysplasia on Index Barrett's Esophagus Diagnosing Endoscopy in a Veteran Population. Clin Gastroenterol Hepatol. 2021. PMID: 33839273. doi:10.1016/j.cgh.2021.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。